Syntal Capital Partners, LLC Zai Lab LTD Transaction History

Syntal Capital Partners, LLC

  • $10 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$126.27 - $191.71 $1.76 Million - $2.67 Million
-13,936 Closed
0 $0
Q4 2020

Feb 11, 2021
BUY
$81.94 - $135.34 $1.14 Million - $1.89 Million
13,936 New
13,936 $1.89 Million
Q3 2020

Oct 26, 2020
SELL
$73.3 - $89.48 $1.28 Million - $1.56 Million
-17,418 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$48.82 - $82.53 $850,346 - $1.44 Million
17,418 New
17,418 $1.43 Million

Others Institutions Holding ZLAB

# of Institutions
145
Shares Held
46.3M
Call Options Held
103K
Put Options Held
439K
View Full List

About Zai Lab Ltd

ZLAB Quotes by TradingView
  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $3.54B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Syntal Capital Partners, LLC Portfolio

Follow Syntal Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syntal Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Syntal Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email